TranscripTx, Inc. is a Menlo Park, California-based company that developed mRNA therapies intended to treat chronic ear sinus and pulmonary disease. The company merged with Recode Therapeutics in 2020.
TranscripTx, Inc. is a Menlo Park, California-based company.
TranscripTx, Inc. is a Menlo Park, California-based company that developed mRNA therapies intended to treat chronic ear sinus and pulmonary disease. The company merged with Recode Therapeutics in 2020.
TranscripTx, Inc. is a biotechnology company that researches and develops genetic medicines. Its develops drugs that target respiratory diseases, including cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). It was founded by Daniel Siegwart and Michael Torres.
TranscripTx, Inc. is a biotechnology company that researches and develops genetic medicines. Its develops drugs that target respiratory diseases, including cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). It was founded by Daniel SiegwartDaniel Siegwart and Michael Torres.
TranscripTx, Inc. is a Menlo Park, California-based company.
TranscripTx, Inc. is a biotechnology company that researches and develops genetic medicines. Its develops drugs that target respiratory diseases, including cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). It was founded by Daniel Siegwart and Michael Torres.